Gln27Glu variant of Beta2-adrenoceptor gene affects male type fat accumulation in women

Lipids in Health and Disease

Volumn 8, Issue , 2009, Pages

  Kunnas, Tarja ^a   Lahtio, Riikka ^a   Kortelainen, Marja Leena ^b   Kalela, Anne ^a   Nikkari, Seppo T ^a,c  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; GLUTAMIC ACID; GLUTAMINE;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INTRAABDOMINAL FAT; MALE; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; BODY MASS INDEX; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMIC ACID; GLUTAMINE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; YOUNG ADULT;

EID: 78650153826     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-8-43     Document Type: Article

References (25)

1. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. A Onat, GS Avci, MM Barlan, H Uyarel, B Uzunlar, V Sansoy, Int J Obes Relat Metab Disord 2004 28 1018 1025 10.1038/sj.ijo.0802695 15197408 (Pubitemid 38998708)
2. Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. JB Albu, L Murphy, DH Frager, JA Johnson, FX Pi-Sunyer, Diabetes 1997 46 456 462 10.2337/diabetes.46.3.456 9032103 (Pubitemid 27090276)
3. Human body composition and the epidemiology of chronic disease. RN Baumgartner, SB Heymsfield, AF Roche, Obes Res 1995 3 73 95 7712363
4. Familial resemblance for abdominal visceral fat: the HERITAGE family study. T Rice, JP Després, EW Daw, J Gagnon, IB Borecki, L Pérusse, AS Leon, JS Skinner, JH Wilmore, DC Rao, C Bouchard, Int J Obes Relat Metab Disord 1997 21 1024 1031 10.1038/sj.ijo.0800511 9368826 (Pubitemid 27462407)
5. Aderenoceptor genes in human obesity. P Arner, J Hoffstedt, J Intern Med 1999 245 667 672 10.1046/j.1365-2796.1999.00495.x 10395196 (Pubitemid 29278875)
6. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. V Large, L Hellström, S Reynisdottir, F Lönnqvist, P Eriksson, L Lannfelt, P Arner, J Clin Invest 1997 100 3005 3013 10.1172/JCI119854 9399946 (Pubitemid 28022837)
7. The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females. L Hellström, V Large, S Reynisdottir, H Wahrenberg, P Arner, J Intern Med 1999 245 253 259 10.1046/j.1365-2796.1999. 0437e.x 10205587 (Pubitemid 29132968)
8. Lack of association between a human beta-2 adrenoceptor gene polymorphism (Gln27Glu) and morbid obesity. B Kortner, A Wolf, D Wendt, U Beisiegel, D Evans, Int J Obes Relat Metab Disord 1999 23 1099 1100 10.1038/sj.ijo.0801063 10557032 (Pubitemid 29476214)
9. Gln27Glu variant of the beta2-adrenergic receptor gene is not associated with obesity and diabetes in Japanese-Americans. T Kawamura, G Egusa, R Fujikawa, M Okubo, Metabolism 2001 50 443 446 10.1053/meta.2001.21695 11288039 (Pubitemid 32321953)
10. Association of adipose tissue deposition and beta-2 adrenergic receptor variants: the IRAS family study. LA Lange, JM Norris, CD Langefeld, BJ Nicklas, LE Wagenknecht, MF Saad, DW Bowden, Int J Obes 2005 29 449 457 (Pubitemid 40592985)
11. Beta2-adrenergic receptor gene polymorphisms and risk of ischemic stroke. R Stanzione, E Di Angelantonio, A Evangelista, D Barbato, S Marchitti, B Zanda, A Pirisi, G Quarta, M Volpe, S Rubattu, Am J Hypertens 2007 20 657 662 10.1016/j.amjhyper.2007.01.006 17531924 (Pubitemid 46777261)
12. GLU-27 variant of beta2-adrenergic receptor polymorphisms is an independent risk factor for coronary atherosclerotic disease. E Barbato, A Berger, L Delrue, F VanDurme, G Manoharan, T Boussy, GR Heyndrickx, B De Bruyne, Q Ciampi, M Vanderheyden, W Wijns, J Bartunek, Atherosclerosis 2007 194 80 86 10.1016/j.atherosclerosis.2006.09.029 17094995 (Pubitemid 47513088)
13. Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. N Sotoodehnia, DS Siscovick, M Vatta, BM Psaty, RP Tracy, JA Towbin, RN Lemaitre, TD Rea, JP Durda, JM Chang, TS Lumley, LH Kuller, GL Burke, SR Heckbert, Circulation 2006 113 1842 1848 10.1161/CIRCULATIONAHA.105.582833 16618831 (Pubitemid 43739395)
14. The Glu27 genotypes of the beta2-adrenergic receptor are predictors for severe coronary artery disease. KK Abu-Amero, OM Al-Boudari, GH Mohamed, N Dzimiri, BMC Med Genet 2006 7 31 10.1186/1471-2350-7-31 16573811 (Pubitemid 43949671)
15. Regulation of beta-adrenoceptor signaling in cardiac function and disease. N Dzimiri, Pharmacol Rev 1999 51 465 501 10471415 (Pubitemid 29420212)
16. Visceral fat and coronary pathology in male adolescents. ML Kortelainen, T Särkioja, Int J Obes Relat Metab Disord 2001 25 228 232 10.1038/sj.ijo.0801466 11410824
17. Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women. T Macho-Azcarate, A Marti, A Gonzalez, JA Martinez, J Ibanez, Int J Obes Relat Metab Disord 2002 26 1434 1441 10.1038/sj.ijo.0802129 12439644 (Pubitemid 36005773)
18. 2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. S Ishiyama-Shigemoto, K Yamada, X Yuan, F Ichikawa, K Nonaka, Diabetologia 1999 42 98 101 10.1007/s001250051120 10027586 (Pubitemid 29039745)
19. 2-adrenergic receptor gene is not associated with morbid obesity in Austrian women. H Oberkofler, H Esterbauer, E Hell, F Krempler, W Patsch, Int J obes Relat Metab Disord 2000 24 388 390 10.1038/sj.ijo.0801180 10757636 (Pubitemid 30137733)
20. 2-adrenoceptor gene of obesity in a French population. A Meirhaeghe, N Helbecque, D Cottel, P Amouyel, Int J Obes Relat Metab Disord 2000 24 382 387 10.1038/sj.ijo.0801168 10757635 (Pubitemid 30137732)
21. 2- adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain. JL Gonzales Sanchez, AM Proenza, MT Martinez Larrad, JM Ramis, C Fernandez Perez, A Palou, M Serrano Rios, Clin Endocrinol 2003 59 476 481 10.1046/j.1365-2265.2003.01871.x (Pubitemid 37188178)
22. Association of codon 16 and codon 27 beta 2-adrenergic receptor gene polymorphisms with obesity: a meta-analysis. MS Jalba, GG Rhoads, K Demisse, Obesity 2008 16 2096 2106 10.1038/oby.2008.327 19186333
23. 2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation. K Masuo, T Katsuya, H Kawaguchi, Y Fu, H Rakugi, T Ogihara, ML Tuck, Am J Hypertens 2006 19 1084 1091 10.1016/j.amjhyper.2006.02.015 17027833 (Pubitemid 44488664)
24. Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism. JA Martinez, MS Corbalan, A Sanchez-Villegas, L Forga, A Marti, MA Martinez-Gonzalez, J Nutr 2003 133 2549 2554 12888635 (Pubitemid 36935968)
25. beta(2)-Adrenergic receptor polymorphisms and determinants of cardiovascular risk: the Cardiovascular Health Study. LA Hindorff, SR Heckbert, BM Psaty, T Lumley, DS Siscovick, DM Herrington, KL Edwards, RP Tracy, Am J Hypertens 2005 3 392 397 10.1016/j.amjhyper.2004.10.014 (Pubitemid 40409922)